FAP and metastatic malignant neoplasm: The study was a single-arm prospective trial that evaluated the ability of a novel imaging agent gallium-68-labeled (68Ga-) FAP-2286 (68Ga-FAP-2286) to detect metastatic cancer in adults with solid tumors using 68Ga-FAP-2286 tracer.